AI assistant
Pfizer Ltd. — Regulatory Filings 2024
Sep 30, 2024
60507_rns_2024-09-30_ba4df1f1-d84d-441b-8d03-1d78b49253cc.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [100 x 42] intentionally omitted <==
Pfizer Limited
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
September 30, 2024
The Corporate Relationship Dept.
The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Closure of Trading Window
We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company for the quarter and half year ending September 30, 2024, the trading window of the Company shall remain closed from Monday, September 30, 2024 (close of business) till 48 hours after the financial results are made public.
We request you to kindly take the same on record.
Thanking you,
Yours truly, For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.09.30 20:03:19 +05'30' Prajeet Nair
Director – Corporate Services & Company Secretary
Cc.: National Securities Depository Limited (NSDL)
Central Depository Services (India) Limited (CDSL) KFin Technologies Limited
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in